BeStock  
Markets › Compare › LBRX vs INVA

LBRX vs INVA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
LBRX · LB Pharmaceuticals$38.85 ▼ 2.97%
INVA · Innoviva$18.41 ▲ 0.00%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

73134196258320Nov 24, '25May 26, '26Nov 20, '26
  • LBRX +140.7%
  • INVA -13.5%

Head to head

MetricLBRXINVA
Price$38.85$18.41
Change today▼ 2.97%▲ 0.00%
Market cap$1.26B$1.31B
Return, 3 months-19.4%-12.5%
Return, year to date+74.5%-7.9%
Return, 1 year+153.4%-12.2%
P/E (TTM)38.37.8
P/B3.01.2
P/E percentile vs own 5y99th61st
Dividend yield––
Revenue growth (YoY, latest qtr)–-1.6%
Net profit growth (YoY)-1,561.0%-182.2%
Gross margin–80.5%
Operating margin–38.8%
Net margin–44.1%
Return on equity-38.8%18.0%
Analyst target vs. price+69.6%+106.4%
Analyst buy share100%100%
RSI (14)4429
30-day volatility63.5%34.7%
Max drawdown, 1 year-31.3%-24.5%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • INVA is the largest of the group by market value.
  • LBRX has returned the most over the past year.
  • INVA carries the lowest trailing P/E.
  • INVA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top